Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 3/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.41 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 3/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.38 |
| ▸ | CES1 | P23141 | 2/20 | 0.38 |
| ▸ | CETP | P11597 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8756382 | 1.00 | EPHX2 (0.41) | EPHX2PKMSOAT2SOAT1MEN1 | |
| SCHEMBL4934443 | 1.00 | EPHX2 (0.41) | EPHX2PKMSOAT2SOAT1MEN1 | |
| SCHEMBL8987951 | 0.98 | MEN1 (0.41) | EPHX2PKMSOAT2SOAT1MEN1 | |
| SCHEMBL4821584 | 0.92 | MEN1 (0.42) | EPHX2PKMMEN1KMT2ANPSR1 | |
| SCHEMBL31365429 | 0.85 | ACE2 (0.40) | EPHX2PKMMEN1KMT2ANPSR1 | |
| SCHEMBL8418702 | 0.83 | EPHX2 (0.44) | EPHX2SOAT2SOAT1MEN1KMT2A | |
| SCHEMBL808497 | 0.83 | MEN1 (0.41) | PKMMEN1KMT2ANPSR1TP53 | |
| SCHEMBL9801863 | 0.82 | TSHR (0.40) | PKMNPSR1TDP1SMN1; SMN2TSHR | |
| SCHEMBL9801905 | 0.82 | TSHR (0.40) | PKMNPSR1TDP1SMN1; SMN2TSHR | |
| SCHEMBL8757520 | 0.82 | TSHR (0.40) | PKMNPSR1TDP1SMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7834220-B2 | 5,5-Diethoxy-(Z3)-3-Pentenyl Methoxymethyl Ether and Preparation Method Thereof | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-11-16 | — | — | US | disclosed |
| US-20100069664-A1 | METHOD FOR PREPARING (E3,Z5)-3,5-ALKADIENYL ACETATE | SHIN-ETSU CHEMICAL CO., LTD. | 2010-03-18 | — | — | US | disclosed |
| US-7638647-B2 | Method for preparing (E3,Z5)-3,5-alkadienyl acetate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-12-29 | — | — | US | disclosed |
| US-7638647-B2 | Method for preparing (E3,Z5)-3,5-alkadienyl acetate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-12-29 | — | — | US | disclosed |
| US-20090143617-A1 | METHOD FOR PREPARING (E3, Z5) -3,5-ALKADIENYL ACETATE | SHIN-ETSU CHEMICAL CO. LTD. | 2009-06-04 | — | — | US | disclosed |
| US-4065620-A | ANTIBIOTICS | ELI LILLY AND COMPANY (US) | 1977-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069664-A1 | METHOD FOR PREPARING (E3,Z5)-3,5-ALKADIENYL ACETATE | APEH, DPP3, LAP3 | EPHX2 818/4885PKM 2061/4885SOAT2 1464/4885 |
| US-20090143617-A1 | METHOD FOR PREPARING (E3, Z5) -3,5-ALKADIENYL ACETATE | APEH, DPP3, LAP3 | EPHX2 818/4885PKM 2061/4885SOAT2 1464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.